Our macular degeneration funded research

Age-related macular degeneration (AMD) is the leading cause of blindness in the aged population in developed countries. There are two types of AMD: dry AMD (also called geographic atrophy, GA) and wet AMD (neovascularisation). Dry AMD accounts for over 80% of AMD incidence, and currently there is no treatment for it. 

At present, these conditions are incurable so more investment in research to identify potential treatments remains crucial.

Around 700,000 people in the UK have late-stage AMD, and nearly 200 people are diagnosed every day. 

Your gift can help find new sight-saving solutions for the UK’s biggest cause of sight loss. 

If you can, please donate today. Thank you.